Гастрацид

Quick links

Choose a section

Quick links to important sections

Advertisements

Гастрацид

Selected form

Advertisements
Advertisements

Overview of Гастрацид

What is Gastracid?

Gastracid is a combined pharmacological agent belonging to the group of antacids. It is designed to neutralize the hydrochloric acid found in gastric juice, helping to manage symptoms associated with high acidity in the digestive tract.

Composition and Mechanism of Action

The preparation typically contains two primary active components: aluminum hydroxide and magnesium hydroxide. These substances work together to provide a rapid and sustained effect on the gastric environment:

  • Neutralization: The active ingredients react chemically with hydrochloric acid to form neutral salts and water. This process reduces the overall acidity of the stomach contents.
  • Cytoprotection: In addition to neutralizing acid, these compounds help enhance the natural protective barriers of the gastric mucosa by stimulating the secretion of mucus and bicarbonates.
  • Adsorption: The components have adsorbent properties, allowing them to bind with bile acids and pepsin, which further reduces the aggressive impact of gastric juices on the stomach lining.

Pharmacological Properties

Unlike some other treatments, Gastracid is considered a non-absorbable antacid. This means its primary action occurs locally within the gastrointestinal tract, and the active substances are not absorbed into the bloodstream in significant quantities. This local action helps minimize systemic effects while providing relief from discomfort.

Therapeutic Use

Gastracid is used to address conditions where excess acid production leads to physical discomfort. It is commonly employed to alleviate symptoms such as:

  • Heartburn (a burning sensation in the chest or throat).
  • Acid regurgitation.
  • Discomfort or pain in the upper abdomen related to gastritis or peptic ulcer disease.

By maintaining the pH of the stomach at a more neutral level, the medication helps protect the esophagus and stomach lining from acid-induced irritation.

Advertisements

What side effects are possible with Гастрацид?

Possible Side Effects and Safety Information

The safety profile of Gastracid (Calcium Carbonate, Magnesium Hydroxide, Simethicone) is documented in official regulatory sources, focusing primarily on common gastrointestinal disturbances and systemic risks linked to the absorption of its ionic components.


Official Adverse Reaction Groupings

The most frequent adverse reactions are generally confined to the Gastrointestinal Disorders system. These effects are often classified as Common in regulatory documents and include diarrhea (associated with the magnesium component) and constipation (associated with the calcium component), as well as nausea, vomiting, and belching.

System-Organ Class Common Adverse Reactions
Gastrointestinal Disorders Diarrhea, Constipation, Nausea, Belching
Metabolism and Nutrition Disorders None (Serious effects are Rare/Not Known)

Serious Safety Considerations

The most serious documented safety concerns are systemic and typically arise from high-dose or prolonged exposure. Reactions such as Milk-alkali syndrome are listed in regulatory documents as a rare complication associated with chronic, excessive ingestion of calcium carbonate with absorbable alkali. Additionally, severe Electrolyte Disturbances, including hypercalcemia (high calcium levels) and hypermagnesemia (high magnesium levels), are known risks associated with systemic ion absorption.


Population and Duration Constraints

Official safety labels note that the risk of systemic effects is significantly elevated in specific populations. Individuals with Renal Impairment or kidney disease are explicitly identified as a high-risk group due to their reduced ability to clear absorbed magnesium and calcium ions, which can lead to the serious complications mentioned above. Furthermore, the risk of systemic reactions is directly linked in regulatory documents to prolonged, high-dose administration beyond the recommended duration.

Advertisements

Overdose and Emergency Response

Overdose with Gastracid (Calcium Carbonate, Magnesium Hydroxide, Simethicone) is documented to result primarily from the systemic effects of excessive Calcium and Magnesium salt ingestion. Manifestations include severe gastrointestinal distress, presenting as persistent diarrhea or severe constipation, alongside early systemic signs such as vomiting, muscle weakness, and lethargy.

Regulator warnings emphasize the potential for severe metabolic imbalance, including documented Hypercalcemia, Hypermagnesemia, and metabolic alkalosis. These imbalances can lead to serious, life-threatening outcomes such as Central Nervous System (CNS) depression, severe hypotension, and potentially dangerous cardiac arrhythmias. A specific regulatory note highlights that patients with pre-existing renal impairment face an increased risk for severe toxicity due to the impaired clearance of the metallic salts.

Officially documented guidance requires patients to seek immediate medical attention upon the known or suspected overdose. Urgent medical help must be sought immediately when systemic signs of toxicity, such as severe confusion, somnolence, or cardiac symptoms, are observed. Hospital monitoring and symptomatic supportive care are required in these cases to manage and correct fluid and severe electrolyte disturbances. No specific antidote is known; treatment is supportive.

Advertisements

Therapeutic Uses of Гастрацид

The primary therapeutic benefit of Gastracid is that it is commonly used to provide symptomatic support for two key domains of discomfort: acid irritation and gas accumulation. It is considered relevant when supportive symptom management is appropriate, particularly in situations involving symptoms related to dietary factors. The therapeutic context of this medication is used for common digestive upsets.


Relief from Heartburn and Acid Indigestion

Gastracid is commonly used for conditions characterized by episodic hyperacidity and its disruptive symptom manifestations. It provides targeted symptomatic support for the specific group of symptoms that cluster around acid indigestion and sour stomach, including the acute, intense burning sensation known as heartburn. The medication helps ease the overall symptom burden, offering short-term supportive relief during periods when symptoms related to irritative states intensify.


Easing Bloating, Pressure, and Functional Flatulence

This medication is also applied in addressing symptoms related to gaseous pressure. It is relevant in contexts marked by increased distress caused by bloating, feelings of abdominal pressure, and functional flatulence (gas). Used when these symptoms create noticeable physiological strain, Gastracid supports the handling of these distressing manifestations. The use contributes to improved day-to-day comfort and helps patients cope more steadily with challenging episodes of abdominal distension.

“This symptomatic support may help patients cope more steadily with challenging episodes of digestive discomfort.”


Quick Fact: Symptomatic support for Heartburn and Bloating ***

Regulatory References

  1. Official DailyMed Drug Label for the combination antacid
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Гастрацид?

This section details the population eligibility and restriction rules for Гастрацид (Calcium Carbonate, Magnesium Hydroxide, Simethicone) based exclusively on government regulatory documents.


Contraindications and Restrictions

Classification Eligibility Rule (Official Labeling)
Absolute Contraindication Individuals with a known hypersensitivity or severe allergic reaction to any component of the formulation.
Standard Eligibility Adults and children 12 years and over are eligible for non-consultative use.
Conditional Use (Ask a Doctor) Children under 12 years, pregnant or breastfeeding individuals, and patients with kidney disease.
Conditional Use (Ask a Doctor) Patients presently taking a prescription drug or those on a magnesium-restricted diet.

The regulatory eligibility profile establishes that standard use is permitted for adults and adolescents aged 12 and older. Use is strictly contraindicated if a component allergy exists. For all other restricted populations—including those with renal impairment, pregnant or breastfeeding individuals, and children under 12—the official labeling mandates consultation with a health professional prior to use, defining a clear conditional framework for safety and eligibility.

Advertisements

What should I know about interactions with other medicines?

The interaction profile of Gastracid (Calcium Carbonate, Magnesium Hydroxide, Simethicone) is primarily defined by pharmacokinetic absorption interference. The polyvalent cations (calcium and magnesium) cause chelation and increase gastric pH, officially leading to a reduction in the systemic exposure (plasma concentration) of many co-administered oral medicines.

This necessitates timing separation between Gastracid and substances like Levothyroxine, Tetracycline antibiotics, Fluoroquinolone antibiotics, and certain Azole Antifungals. Regulatory documents mandate administering these agents at least 2 to 4 hours apart to mitigate reduced absorption.

Pharmacodynamic interactions are also officially noted. Co-administration of the magnesium component with Sodium Polystyrene Sulfonate is associated with an increased risk of intestinal obstruction. Furthermore, the magnesium component may increase the toxicity of Digitalis Glycosides (e.g., Digoxin) via additive effects on serum electrolytes. The combination with Eltrombopag is explicitly listed as a restricted combination due to significant reduction in the active drug's exposure.

A key population-specific constraint is noted for patients with renal impairment. Reduced kidney function officially heightens the risk of hypermagnesemia and hypercalcemia due to reduced clearance of the active ions.

Advertisements

Mechanism of Action

Direct Chemical Neutralization of Acidity

This domain is governed by the immediate, stoichiometric chemical reaction of the antacid bases ( Calcium Carbonate and Magnesium Hydroxide) with hydrochloric acid ( HCl) within the stomach lumen. This mechanism leads to a rapid and pronounced pH increase, which causes the proteolytic enzyme Pepsin to become inactive and reduces the concentration of chemical irritants on the mucosa.


Physio-chemical Modulation of Gas Structure

This domain is defined by the anti-flatulence component, Simethicone, which exerts its action through a purely physical, non-absorbable mechanism. By reducing the surface tension of the gas-liquid interface, the compound causes multiple small gas bubbles to coalesce into fewer, larger bubbles , allowing for easier physiological expulsion from the gastrointestinal tract via eructation or flatus.


Mechanistic Synergy and Limitations

The combination leverages kinetic synergy—the rapid onset of one component balanced by the sustained effect of the other—to achieve a balanced pH modulation profile. However, the Calcium^2+ ion released by one salt can engage regulatory pathways to stimulate Gastrin release, predisposing the system to a secondary increase in acid secretion once the neutralizing effect is no longer active.

Advertisements

Dosage and Administration Information

Administration of Гастрацид: Guidelines

The usage of Гастрацид (a combination of Calcium Carbonate, Magnesium Hydroxide, and Simethicone) is structured as an oral, as-needed (PRN) intervention.

Instruction Detail
Route of Administration Oral via either chewable tablets or liquid oral suspension.
Dosing Schedule and Limit The standard adult dose (12 years and older) is 2 to 4 tablets or 10 mL to 20 mL of suspension per dose. The maximum daily intake is generally restricted to 7 to 8 doses or the equivalent volume/tablet count in a 24-hour period.
Timing in Relation to Meals Dosing is typically directed for use after meals and at bedtime, or may be taken between meals.
Preparation Requirements Chewable tablets must be chewed completely before swallowing; they are not to be swallowed whole. The liquid suspension must be shaken well before the dose is measured and administered.
Age-Group Rules Approved for use in adults and children 12 years and older. Administration to children under 12 years of age is permitted only as directed by a doctor.
Special Procedural Conditions The maximum dose must not be used for more than two weeks of continuous, non-supervised self-medication.

The instructions establish the use of this product as a short-term, acute intervention. The dosing is driven by the occurrence of symptoms, with defined numerical limits on frequency and dose size. This protocol ensures that the administration of the medicine follows a standardized approach.

Advertisements

Recent Clinical Evidence

Evidence for Symptomatic Relief of Heartburn and Acid Indigestion

Research has examined the antacid components of Гастрацид in short-term Randomized Controlled Trials (RCTs). These studies were applied in research contexts exploring how symptoms change over time in conditions characterized by episodic heartburn and acid indigestion. Outcomes monitored included physiological measures, such as temporary shifts in the pH level of the stomach. Findings describe patterns observed where administration was associated with changes in patient reports, informing the regulatory status for acute use assessment of antacids.

Evidence for Managing Bloating, Pressure, and Functional Flatulence

Systematic reviews and clinical studies were used to explore the anti-flatulence component. Research examined patient-reported outcomes describing perceived discomfort related to gas, bloating, and abdominal pressure. Studies report how symptoms evolved in the observed populations, and findings indicate that the use of this component may be associated with patterns in patient-reported outcomes. Evidence quality varies across studies compared to the antacid components, and follow-up durations are often limited.

Key Limitations and Research Gaps

Clinical research primarily focuses on acute use assessment and explores short-term symptom changes; long-term effects are not fully established. Comparative evidence is lacking for the specific contribution of the anti-flatulence component when added to an antacid. Furthermore, data for certain groups remain insufficient, especially for older adults with comorbidities. The results apply only to the populations studied (predominantly adults and adolescents), and research is ongoing to better contextualize all findings.

Key Studies & References

  1. Official DailyMed Drug Label for Calcium Carbonate, Magnesium Hydroxide, and Simethicone Combination
  2. World Gastroenterology Organisation Global Guidelines: Dyspepsia and Gastoesophageal Reflux Disease
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Гастрацид (FAQ)


Q: How quickly does Гастрацид usually start to work?

Official information describes Гастрацид as a fast-acting product. This is because its main components are antacids, which work through a direct chemical reaction in the stomach to quickly neutralize existing acid and increase the pH level.


Q: How long does the effect of Гастрацид typically last?

Antacids are generally characterized as providing a shorter duration of effect compared to medicines that stop the body from producing acid. The product is characterized by official labeling as a source of fast-acting, temporary relief of acute symptoms.


Q: What does the research say about the long-term use of Гастрацид?

Regulatory documents advise that the maximum recommended dose for Гастрацид should not be used for more than two weeks of continuous self-medication. Serious risks are associated with chronic, excessive ingestion, including a rare condition called Milk-alkali syndrome and disturbances in the body's electrolyte balance.


Q: Why does the label mention not using Гастрацид continuously for more than a few weeks?

The duration constraint is set because prolonged, high-dose administration increases the risk of systemic adverse reactions. These effects are related to the absorption of the active ions, such as calcium and magnesium, which can lead to dangerously high levels (hypercalcemia or hypermagnesemia) in the blood.


Q: What is the difference between Гастрацид and medicines that reduce acid production?

Гастрацид is classified as an antacid, which functions by neutralizing the stomach acid that has already been produced. In contrast, other medicines like proton pump inhibitors (PPIs) and H2-blockers work to reduce the secretion of acid in the first place.


Q: What are the signs that Гастрацид is working for me?

The product is indicated for the temporary relief of symptoms associated with heartburn, acid indigestion, and gas or bloating. Its purpose is to alleviate these specific discomforts.


Q: Are the reported side effects generally mild?

Official labeling distinguishes between common adverse reactions, which are typically confined to the digestive system (like diarrhea or constipation), and rare but serious safety concerns that relate to systemic effects from high-dose or prolonged use.


Q: Are there specific storage instructions for Гастрацид?

Yes, regulatory guidelines specify storing the product at Controlled Room Temperature (20 to 25 C). The medicine should also be protected from excessive heat and moisture, and the container should be tightly closed and kept out of the sight and reach of children.


Q: Is it possible for Гастрацид to cause an allergic reaction?

Yes. Official product documentation lists a known hypersensitivity or severe allergic reaction to any component of the formulation as an absolute contraindication. Individuals with known allergies to any ingredient are advised against using the product.


Q: Is Гастрацид available without a prescription?

Yes, Гастрацид is officially designated as an Over-the-Counter (OTC) medication. This status indicates that it is available for non-consultative use for approved, short-term purposes.


Q: Can older adults use Гастрацид safely?

Official labels do not explicitly restrict use for older adults as a group. However, official documents state that consultation with a health professional is advised for patients taking a prescription drug or those with underlying conditions, such as kidney disease.


Q: Does Гастрацид interact with vitamins or mineral supplements?

Antacids are generally noted to interfere with the absorption of certain minerals (such as iron or zinc) and vitamins by altering the acidity in the stomach. The principle of timing separation is often noted when taking antacids with supplements to minimize the potential for absorption interference.


Q: Is Гастрацид considered a proton pump inhibitor (PPI)?

No, Гастрацид is classified as an antacid/anti-flatulence combination agent. Proton pump inhibitors (PPIs) are a separate class of medicines that specifically work to stop the cells in the stomach from producing acid.


Q: How long is Гастрацид typically prescribed for?

For self-medication, regulatory guidance specifies a maximum duration of two weeks. For prescribed use, a doctor determines the appropriate length of therapy, but antacids are primarily utilized for short-term, acute intervention to manage symptoms.


Q: Is the effectiveness of Гастрацид different based on the specific condition being treated?

The drug is formulated as a combination to address two different symptom groups: the antacid components target acid indigestion and heartburn, while the simethicone component targets gas and bloating. This dual action aims to manage the different symptoms for which it is indicated.


Q: Has Гастрацид been studied in pregnant women?

Antacid components are generally described in medical literature as having minimal systemic absorption, which minimizes exposure to a developing fetus. However, official product labeling advises that pregnant or breastfeeding individuals should consult a health professional before using the product.


Q: Does Гастрацид contain any common allergens like gluten or lactose?

The presence or absence of specific common allergens like gluten or lactose is typically listed in the inactive ingredients section of the specific product label. Verifying the inactive ingredients section is recommended to confirm the contents of a particular formulation.


Q: Can I use Гастрацид if I have diabetes?

Some formulations of Гастрацид may contain sugars or artificial sweeteners listed in the inactive ingredients. People with diabetes should verify the specific inactive ingredients on the product label to ensure it aligns with their dietary considerations.


Q: Are there different strengths or forms of Гастрацид available?

Yes. Гастрацид is available in different forms, such as chewable tablets and liquid oral suspension. Additionally, the medicine may be offered in various strengths of its active components, such as 'Regular Strength' or 'Ultra Strength' options.


Q: Can using Гастрацид affect the results of blood tests?

The product's active ingredients are absorbed as calcium and magnesium ions. Prolonged, high-dose use can lead to measurable changes in serum electrolyte levels, and monitoring of these levels is a safety consideration noted in regulatory documents.


Q: Can Гастрацид be used to treat ulcers?

The drug is officially indicated for the relief of symptoms like heartburn and acid indigestion. It is not typically listed in regulatory documents as a primary or sole treatment for ulcers, which generally require a specific course of prescription therapy.


Q: Is the medication meant for occasional or daily use?

The medication is administered on an as-needed (PRN) basis for the temporary relief of symptoms. Continuous use at the maximum dose is restricted to no more than two weeks without consultation from a doctor.


Q: Why is it important to check the ingredients of Гастрацид if I am on a low-salt diet?

Regulatory guidance often includes an advisory statement recommending consultation with a doctor before using the product if a patient is following a sodium-restricted diet. This is because some antacid formulations contain amounts of sodium.


Q: Can I break or crush the Гастрацид tablet?

The chewable tablets are explicitly directed in the instructions for use to be chewed completely before swallowing and should not be swallowed whole. The liquid suspension must be shaken before measuring the dose.


Q: Is it okay to use Гастрацид while consuming alcohol?

While regulatory labels may not list a specific drug-alcohol interaction for Гастрацид, medical guidance generally advises avoiding substances like alcohol and caffeine as they can increase the production of stomach acid, potentially counteracting the medication's intended effect.


Q: What happens if I miss using Гастрацид?

The medication is used as needed for the relief of symptoms. Since it is not a scheduled daily medication, a 'missed dose' is not a point of concern; one would simply use the next dose when symptoms occur.


Q: Can Гастрацид be taken with pain relievers like paracetamol?

The general principle of interactions is that Гастрацид can interfere with the absorption of many other medications due to the pH change it causes in the stomach. Therefore, timing separation is often noted as a principle to follow when taking antacids with oral medications.

Advertisements

How should Гастрацид be stored and disposed of?

Storage Requirements

Condition Regulatory Requirement
Temperature Store at Controlled Room Temperature (CRT), defined as 20 to 25 C (68 to 77 F), with permitted excursions up to 30 C (86 F).
Environmental Protect from excessive heat and moisture; the liquid suspension form must not freeze.
Packaging Keep the medicine in its original container and ensure the bottle is tightly closed.
Child Safety Must be stored out of the sight and reach of children and pets.

Disposal Instructions

Official regulatory guidelines determine the proper disposal of unused or expired product. The preferred method is to utilize a community drug take-back program or mail-back option. If these options are unavailable, the medicine can generally be disposed of in household trash after being mixed with an undesirable substance (e.g., used coffee grounds or kitty litter) and placed in a sealed container to prevent diversion. It is required to scratch out all personal identifying information on the label before discarding the container. Disposal by flushing down a toilet or sink is generally discouraged unless the product label explicitly instructs it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Гастрацид found in:

A-Z Index: